middle.news
Botanix’s ECCLOCK® Gel Gains South Korean Approval, Launch Set for 2026
8:35am on Friday 5th of September, 2025 AEST
•
Healthcare
Read Story
Botanix’s ECCLOCK® Gel Gains South Korean Approval, Launch Set for 2026
8:35am on Friday 5th of September, 2025 AEST
Key Points
ECCLOCK® gel approved by South Korean Ministry of Food and Drug Safety
Launch planned for Q1 2026 by sublicensee Dongwha Pharm
Manufacturing to be handled by Kaken Pharmaceutical in Japan
Botanix to receive 50% royalties from Kaken’s South Korean sales
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Botanix Pharmaceuticals (ASX:BOT)
OPEN ARTICLE